Basic Information
ID: ALA4135020
Type: Functional
Description: Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 4 days by MTT assay
Format: BAO_0000218
Organism: Human immunodeficiency virus 1
Strain: 3B
Target: Human immunodeficiency virus 1(ALA378)
Document: ALA4130485
Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 4 days by MTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4135020
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 315.68 | 4.07 | 4.07 |
| 395.46 | 3.83 | 3.83 |
| 411.91 | 4.34 | 4.34 |
| 395.46 | 3.83 | 3.83 |
| 377.47 | 3.69 | 3.69 |
| 411.91 | 4.34 | 4.34 |
| 391.50 | 4.00 | 4.00 |
| 391.50 | 4.00 | 4.00 |
| 487.56 | 5.62 | 5.62 |
| 518.04 | 5.92 | 5.92 |
| 483.59 | 5.27 | 5.27 |
| 504.01 | 6.14 | 6.14 |
| 501.58 | 5.41 | 5.41 |
| 518.04 | 5.92 | 5.92 |
| 411.91 | 4.34 | 4.34 |
| 483.59 | 5.79 | 5.79 |
| 487.56 | 5.62 | 5.62 |
| 391.50 | 4.00 | 4.00 |
| 518.04 | 5.92 | 5.92 |
| 497.62 | 5.58 | 5.58 |
| 395.46 | 3.83 | 3.83 |
| 483.59 | 5.79 | 5.79 |
| 504.01 | 6.14 | 6.14 |
| 497.62 | 5.58 | 5.58 |
| 469.57 | 5.48 | 5.48 |
| 504.01 | 6.14 | 6.14 |
| 487.56 | 5.62 | 5.62 |
| 501.58 | 5.41 | 5.41 |
| 501.58 | 5.41 | 5.41 |
| 483.59 | 5.79 | 5.79 |
| 497.62 | 5.58 | 5.58 |